ViroPharma Incorporated - Strategy and SWOT Report
MarketLine, January 2012, Pages: 43
ViroPharma Incorporated - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on ViroPharma Incorporated required for business and competitor intelligence needs
- A study of the major internal and external factors affecting ViroPharma Incorporated in the form of a SWOT analysis
- An in-depth view of the business model of ViroPharma Incorporated including a breakdown and examination of key business segments
- Intelligence on ViroPharma Incorporated’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about ViroPharma Incorporated, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
ViroPharma is a global biotechnology company dedicated to the development and commercialization of products that address serious diseases. The company is headquartered in Exton, Pennsylvania and employed 232 people as of December 31, 2010. The company recorded revenues of $439 million during the financial year ended December 2010 (FY2010), an increase of 41.4% over FY2009. The operating profit of the company was $211.7 million during FY2010, as compared to operating profit of $32.1 million in FY2009. The net profit was $125.6 million in FY2010, as compared to net loss of $11.1 million in FY2009.
Reasons to Purchase:
- Gain understanding of ViroPharma Incorporated and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess ViroPharma Incorporated as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on ViroPharma Incorporated’s business structure, strategy and prospects
Company Snapshot
ViroPharma Incorporated: Company Overview
ViroPharma Incorporated: Overview and Key Facts
ViroPharma Incorporated: Overview
ViroPharma Incorporated: Key Facts
ViroPharma Incorporated: Key Employees
ViroPharma Incorporated: Key Employee Biographies
ViroPharma Incorporated: Major Products and Services
ViroPharma Incorporated: Company History
ViroPharma Incorporated: Management Statement
ViroPharma Incorporated: Locations and Subsidiaries
ViroPharma Incorporated: Key Competitors
ViroPharma Incorporated: Company Analysis
ViroPharma Incorporated: Business Description
ViroPharma Incorporated: SWOT Analysis
ViroPharma Incorporated: SWOT Overview
ViroPharma Incorporated: Strengths
ViroPharma Incorporated: Weaknesses
ViroPharma Incorporated: Opportunities
ViroPharma Incorporated: Threats
ViroPharma Incorporated: Corporate Financial Deals Activity
ViroPharma Incorporated: Financial Deals Overview
ViroPharma Incorporated: Targets and Partners
ViroPharma Incorporated: Top Deals 2007 -YTD-2012
ViroPharma Incorporated: Advisors
ViroPharma Incorporated: Top Financial Advisors
ViroPharma Incorporated: Mergers and Acquisitions
ViroPharma Incorporated: Partnership
ViroPharma Incorporated: Recent Developments
ViroPharma Incorporated: News and Events Summary
ViroPharma Incorporated: Contracts
ViroPharma Incorporated: Financial Performance
ViroPharma Incorporated: Regulatory and Legal Events
ViroPharma Incorporated: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor
List of Tables
Table 1: ViroPharma Incorporated: Key Facts
Table 2: ViroPharma Incorporated: Key Employees
Table 4: ViroPharma Incorporated: Key Competitors
Table 5: ViroPharma Incorporated: Deal Activity by Deal Type - Volume (TTM)
Table 6: ViroPharma Incorporated: Deal Activity by Deal Type - Volume (2008 - YTD-2012)
Table 7: ViroPharma Incorporated: M&A Average Deal Size - Value (US$m)
Table 8: ViroPharma Incorporated: Targets and Partners
Table 9: ViroPharma Incorporated: Top Deals 2007 -YTD-2012
Table 10: ViroPharma Incorporated: Financial Advisor Ranking by Value (US$m)
Table 11: ViroPharma Incorporated: M&A Volume and Value Trend (2008 - YTD-2012)
Table 12: ViroPharma Incorporated: M&A Activity by Geography (2008 - YTD-2012)
Table 13: ViroPharma Incorporated: Partnership Volume and Value Trend (2008 - YTD-2012)
Table 14: ViroPharma Incorporated: Partnership Trend by Deal Type (2008 - YTD-2012)
Table 15: ViroPharma Incorporated: News and Events Summary
Table 16: ViroPharma Incorporated: Contracts
Table 17: ViroPharma Incorporated: Financial Performance
Table 18: ViroPharma Incorporated: Regulatory and Legal Events
Table 19: ViroPharma Incorporated: Research & Development
List of Figures
Figure 1: ViroPharma Incorporated: Deal Activity by Deal Type - Volume (TTM)
Figure 2: ViroPharma Incorporated: Deal Activity by Deal Type - Volume (2008 - YTD-2012)
Figure 3: ViroPharma Incorporated: M&A Average Deal Size - Value (US$m)
Figure 4: ViroPharma Incorporated: M&A Volume and Value Trend (2008 - YTD-2012)
Figure 5: ViroPharma Incorporated: M&A Activity by Geography (2008 - YTD-2012)
Figure 6: ViroPharma Incorporated: Partnership Volume and Value Trend (2008 - YTD-2012)
Figure 7: ViroPharma Incorporated: Partnership Trend by Deal Type (2008 - YTD-2012)
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
